ORIGINAL RESEARCH article

Front. Mol. Biosci.

Sec. Molecular Diagnostics and Therapeutics

Volume 12 - 2025 | doi: 10.3389/fmolb.2025.1596364

This article is part of the Research TopicAdvancements in Immune Heterogeneity in Inflammatory Diseases and Cancer: New Targets, Mechanisms, and StrategiesView all 16 articles

Identification of diagnostic hub genes related to energy metabolism in idiopathic pulmonary fibrosis

Provisionally accepted
Shu  ZhaoShu Zhao*Bichen  SunBichen SunNa  LiuNa LiuRan  HuoRan HuoLishi  LiuLishi LiuJiepeng  WangJiepeng WangChaoyi  FangChaoyi Fang
  • Hebei University of Chinese Medicine, Shijiazhuang, Hebei Province, China

The final, formatted version of the article will be published soon.

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease characterized by irreversible respiratory failure. Emerging evidence implicates dysregulated energy metabolism in driving fibroblast activation and extracellular matrix remodeling during IPF pathogenesis. To systematically investigate metabolic reprogramming mechanisms, we performed integrated bioinformatics analyses focusing on energy metabolism-related differentially expressed genes (EMRDEGs) and their regulatory networks in fibrotic remodeling.Methods: Differentially expressed genes (DEGs) were identified using GEO datasets GSE242063 and GSE110147. Energy metabolism-related genes (EMRGs) were extracted from GeneCards, followed by Venn diagram analysis to obtain EMRDEGs.Subsequent analyses included functional enrichment (GO/KEGG), protein-protein interaction networks, and mRNA-miRNA/TF regulatory networks. Immune infiltration analyses, including the CIBERSORT algorithm, and single-sample gene set enrichment analysis (ssGSEA), were subsequently conducted.: We identified 12 EMRDEGs and eight hub genes (ACSL1, CEBPD, CFH, HMGCS1, IL6, SOCS3, TLR2, and UCP2). Regulatory network analysis revealed HMGCS1 as a novel IPF-associated gene interacting with PPARα signaling, while SOCS3 coordinated multiple hub genes (IL6, CEBPD, UCP2, and CFH) through FOXA1/2-mediated transcriptional regulation alongside JAK/STAT3 pathway suppression. Immune profiling demonstrated significant hub gene-immune cell correlations, particularly neutrophil-mediated differential gene expression and microenvironment remodeling. Conclusion: The core EMRDEGs (HMGCS1 and SOCS3) and prioritized pathways (PPARα signaling, FOXA networks, JAK/STAT3 suppression) elucidate metabolic reprogramming mechanisms in fibrotic progression. These molecular signatures provide novel clinical biomarkers for IPF diagnosis.

Keywords: IPF (Idiopathic pulmonary fibrosis), hub genes, energy matebolism, GEO, DGE analysis

Received: 19 Mar 2025; Accepted: 04 Jun 2025.

Copyright: © 2025 Zhao, Sun, Liu, Huo, Liu, Wang and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Shu Zhao, Hebei University of Chinese Medicine, Shijiazhuang, 050200, Hebei Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.